1. Home
  2. CDXC vs TCBX Comparison

CDXC vs TCBX Comparison

Compare CDXC & TCBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXC
  • TCBX
  • Stock Information
  • Founded
  • CDXC 1999
  • TCBX 2008
  • Country
  • CDXC United States
  • TCBX United States
  • Employees
  • CDXC N/A
  • TCBX N/A
  • Industry
  • CDXC Medicinal Chemicals and Botanical Products
  • TCBX Banks
  • Sector
  • CDXC Health Care
  • TCBX Finance
  • Exchange
  • CDXC Nasdaq
  • TCBX Nasdaq
  • Market Cap
  • CDXC 546.9M
  • TCBX 473.0M
  • IPO Year
  • CDXC N/A
  • TCBX 2021
  • Fundamental
  • Price
  • CDXC $7.63
  • TCBX $35.27
  • Analyst Decision
  • CDXC Strong Buy
  • TCBX Buy
  • Analyst Count
  • CDXC 2
  • TCBX 4
  • Target Price
  • CDXC $8.00
  • TCBX $25.50
  • AVG Volume (30 Days)
  • CDXC 3.0M
  • TCBX 122.7K
  • Earning Date
  • CDXC 10-31-2024
  • TCBX 10-23-2024
  • Dividend Yield
  • CDXC N/A
  • TCBX N/A
  • EPS Growth
  • CDXC N/A
  • TCBX 38.69
  • EPS
  • CDXC 0.02
  • TCBX 2.56
  • Revenue
  • CDXC $91,668,000.00
  • TCBX $158,911,000.00
  • Revenue This Year
  • CDXC $18.64
  • TCBX N/A
  • Revenue Next Year
  • CDXC $20.72
  • TCBX $8.66
  • P/E Ratio
  • CDXC $388.80
  • TCBX $13.79
  • Revenue Growth
  • CDXC 9.95
  • TCBX 17.73
  • 52 Week Low
  • CDXC $1.32
  • TCBX $16.52
  • 52 Week High
  • CDXC $7.85
  • TCBX $36.20
  • Technical
  • Relative Strength Index (RSI)
  • CDXC 75.32
  • TCBX 70.21
  • Support Level
  • CDXC $6.80
  • TCBX $34.98
  • Resistance Level
  • CDXC $7.67
  • TCBX $36.20
  • Average True Range (ATR)
  • CDXC 0.58
  • TCBX 1.03
  • MACD
  • CDXC 0.07
  • TCBX -0.10
  • Stochastic Oscillator
  • CDXC 91.16
  • TCBX 79.52

About CDXC ChromaDex Corporation

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.

About TCBX Third Coast Bancshares Inc.

Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company has one segment, community banking, it generates most of its revenue from interest on loans, customer service, and loan fees.

Share on Social Networks: